Walz, J.

patient disease sc disease cancer prostate <0.001 prostate cancer surgery urology nomogram survival prostatectomy european treatment stage prostate-speci fic antigen lymph node dissection outcome gleason biopsy study accuracy factor model adjuvant table number briganti lymph tumor stage department biopsy gleason sum csm-free survival rates 1366 patients multivariable preoperative tumor analyses therapy joniau characteristic specimen-confined disease lymph node invasion control institution 584–592 score recurrence –free survival spahn result university association preoperative risk factors non-sc disease cancer control regression value sc pca gontero predictor range pca patients antigen 1.00 risk factors –specimen disease kaplan-meier analysis specimen-confined assessment guideline presence limitation dissection prostate-speci candidate probability cancer network status specimen